
Trump Administration Pushes for Fair Global Drug Pricing
The Trump administration has successfully negotiated nine new pricing agreements with drug manufacturers, potentially reducing prescription medicine costs for Americans. This initiative underscores President Trump’s commitment to lowering drug prices through individual negotiations rather than broad mandates. While commendable, a focus on reducing foreign free-riding on American drug innovation would yield more substantial results. For […]








